Pindolol NDC 82804-940

Product information

Brand name (proprietary)

Pindolol

Generic name (nonproprietary)

pindolol

Active ingredients

Pindolol — 10 mg/1

Dosage form

Tablet

Route

Oral

Labeler

Proficient Rx LP

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 205415

Marketing start

Nov 18, 2025

Listing expires

Dec 31, 2027

Other FDA classes

Adrenergic beta-Antagonists (Mechanism)

Identifiers

Product ID 82804-940_b7e273a6-e810-4a03-88cd-ff3376e244c3SPL ID b7e273a6-e810-4a03-88cd-ff3376e244c3

Pharmacologic class

beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482804094000 followed by a unit qualifier and the quantity Copy

Package 82804-0940-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under ANDA 205415

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.